Pricing Log in Create free account

Cellyan Biotechnology Co., Ltd (HKPD) vs 111, Inc. Sponsored ADR (YI)

Cellyan Biotechnology Co., Ltd and 111, Inc. Sponsored ADR are both Medical Distribution companies. Cellyan Biotechnology Co., Ltd and 111, Inc. Sponsored ADR are of similar size ($17.1M and $16.0M). Across the 8 metrics below, Cellyan Biotechnology Co., Ltd leads on 4 and 111, Inc. Sponsored ADR on 4.

Valuation

Metric HKPD YI Medical Distribution median
P/E — n/m —
P/S — 0.02 0.27
P/B n/m n/m —
Price to free cash flow n/m n/m —
EV/EBITDA n/m n/m 17.78
EV/Sales n/m 0.00 0.63
Earnings yield — (45.31%) (6.67%)
Free cash flow yield 0.00% (76.21%) 0.00%

Profitability

Metric HKPD YI Medical Distribution median
Gross margin — 5.74% 8.01%
Operating margin — (0.20%) 0.46%
Net margin — (0.75%) (6.08%)
Free cash flow margin 0.00% (0.71%) 0.00%
Return on equity 0.00% 12.26% 0.00%
Return on assets 0.00% (3.89%) 0.00%
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric HKPD YI Medical Distribution median
Revenue growth (TTM) — (16.19%) 11.54%
EPS growth (last fiscal year) (2,492.59%) (900.00%) 5.71%
Revenue growth, 5-year CAGR — 7.39% 8.18%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HKPD YI Medical Distribution median
Debt to equity 0.10 (0.34) (0.34)
Current ratio 3.86 1.08 1.05
Net debt to EBITDA (0.79) (44.78) (0.01)

Dividend

Metric HKPD YI Medical Distribution median
Dividend yield — — —
Payout ratio — — —

Size

Metric HKPD YI Medical Distribution median
Market cap 17.11m 16.04m 154.79m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack